Mativ Holdings, Inc. (MATV) earnings date, results and what the price requires
NYSE · SEC CIK 0001000623 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $531.8M | $3.6M | $0.06 | Filing |
| Mar 31, 2026 | May 6, 2026 | $479.6M | $-11.7M | $-0.22 | Filing |
| Dec 31, 2025 | Feb 18, 2026 | $463.1M | $100.8M | $1.87 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | $513.7M | $-3.2M | $-0.06 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | $525.4M | $-9.5M | $-0.18 | Filing |
| Mar 31, 2025 | May 7, 2025 | $484.8M | $-425.5M | $-7.82 | Filing |
| Dec 31, 2024 | Feb 19, 2025 | $458.6M | $1.5M | $0.03 | Filing |
| Sep 30, 2024 | Nov 6, 2024 | $498.5M | $-20.8M | $-0.38 | Filing |
What would Mativ Holdings, Inc. have to report for its valuation to change?
At $11.21, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -10.3% a year, to $0.96. On that path the next quarter needs diluted EPS near $-0.05, against $-0.06 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -10.3% | -10.3% |
| EPS needed in final year | $0.96 | $0.96 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. MATV goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.